Numerai GP LLC Reduces Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Numerai GP LLC lowered its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 64.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,570 shares of the company's stock after selling 8,343 shares during the period. Numerai GP LLC's holdings in U.S. Physical Therapy were worth $405,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in U.S. Physical Therapy by 3.4% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,506 shares of the company's stock valued at $755,000 after buying an additional 282 shares during the last quarter. Lazard Asset Management LLC bought a new position in shares of U.S. Physical Therapy during the fourth quarter valued at $84,000. Deutsche Bank AG raised its position in shares of U.S. Physical Therapy by 49.3% in the 4th quarter. Deutsche Bank AG now owns 13,176 shares of the company's stock worth $1,169,000 after purchasing an additional 4,350 shares during the last quarter. D. E. Shaw & Co. Inc. boosted its stake in U.S. Physical Therapy by 44.9% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 87,184 shares of the company's stock worth $7,734,000 after purchasing an additional 27,028 shares in the last quarter. Finally, Cubist Systematic Strategies LLC purchased a new stake in U.S. Physical Therapy during the 4th quarter valued at about $586,000.

Wall Street Analyst Weigh In

USPH has been the subject of several recent analyst reports. StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. JPMorgan Chase & Co. decreased their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Barrington Research reduced their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday, February 28th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $109.00.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at $588,564.48. This trade represents a 19.44% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 2.00% of the stock is owned by corporate insiders.

U.S. Physical Therapy Stock Performance

USPH stock traded down $1.08 on Wednesday, hitting $78.32. The company had a trading volume of 14,368 shares, compared to its average volume of 110,489. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $106.06. The stock has a market cap of $1.19 billion, a price-to-earnings ratio of 83.34, a P/E/G ratio of 3.54 and a beta of 1.44. The stock's 50-day simple moving average is $71.94 and its 200 day simple moving average is $83.53.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.02. The firm had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company's revenue was up 18.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.51 EPS. As a group, equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 23rd will be given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 2.30%. The ex-dividend date is Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio is currently 82.57%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.